Unexpectedly high frequency of European parentage in Venezuelan patients with chronic lymphocytic leukemia

References

• Rassenti LZ, Jain S, Keating MJ, . Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 2008;112:1923–1930.
   PubMed Web of Science ®Google Scholar
• Binet JL, Lepoprier M, Dighiero G, . A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855–864.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Damle RN, Wasil T, Fais F, . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
   PubMed Web of Science ®Google Scholar
• Durig J, Naschar M, Schmucker U, . CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 2002;16:30–35.
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, . ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764–1775.
   PubMed Web of Science ®Google Scholar
• Duke VM, Gandini D, Sherrington PD, . V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003;88:1259–1271.
   PubMed Web of Science ®Google Scholar
• Rassenti LZ, Huynh L, Toy TL, . ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893–901.
   PubMed Web of Science ®Google Scholar
• Hamblin TJ, Davis Z, Gardiner A, . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
   PubMed Web of Science ®Google Scholar
• Maloum K, Davi F, Merle-Beral H, . Expression of unmutated V(H) genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000;96:377–379.
   PubMed Web of Science ®Google Scholar
• Morilla A, Gonzalez de Castro D, Del Giadice I, . Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. Leuk Lymphoma 2008;49:2108–2115.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Johnson A, . Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003;101:4952–4957.
   PubMed Web of Science ®Google Scholar
• Widhopf GF, Rassenti LZ, Toy TL, . Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004;104:2499–2504.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang Y, Zheng W, . Distinctive IGVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008;32:1491–1498.
   PubMed Web of Science ®Google Scholar
• Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, . Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Cancer Sci 2009;100:2346–2353.
   PubMed Web of Science ®Google Scholar
• Hojjat Farsangi M, Jeddi-Tehrani M, Sharifian RA, . Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with choronic lymphocytic leukemia. Leuk Lymphoma 2006;48:109–116.
   Web of Science ®Google Scholar
• Koiso H, Yamane A, Mitsui T, . Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia. Leuk Res 2006;30:272–276.
   PubMed Web of Science ®Google Scholar
• Boggs DR, Chen SC, Zhang ZN, . Chronic lymphocytic leukemia in China. Am J Hematol 1987;25:349–354.
   PubMed Web of Science ®Google Scholar
• Gale RP, Cozen W, Goodman MT, . Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County. Leuk Res 2000;24:665–669.
   PubMed Web of Science ®Google Scholar
• Irons RD, Le A, Bao L, . Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res 2009;33:1599–1603.
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles GJ, Velazquez BM, Apreza-Molina MG, . Chronic lymphocytic leukemia is frequent in Mexican mestizos. Int J Hematol 1999;69:253–255.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Grever M, . National Cancer Institute-Sponsored Working Group Guidelines for Chronic Lymphocytic Leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
   PubMed Web of Science ®Google Scholar
• Deglesne PA, Chevallier N, Letestu R, . Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. Cancer Res 2006;66:7158–7166.
   PubMed Web of Science ®Google Scholar
• Marquez ME, Deglesne PA, Suarez G, . MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal. Int J Lab Hematol 2010;33:194–200.
   PubMed Web of Science ®Google Scholar
• Murray F, Darzentas N, Hadzidimitriou A, . Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524–1533.
   PubMed Web of Science ®Google Scholar
• Nardini E, Neri F, Vicenzi E, . Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer 2003;107:958–961.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Karlsson K, . Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004;104:2879–2885.
   PubMed Web of Science ®Google Scholar
• Crowther-Swanepoel D, Wild R, Sellick G, . Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IGVH gene usage and mutation status in familial CLL. Blood 2008;111:5691–5693.
   PubMed Web of Science ®Google Scholar
• Messmer BT, Raphael BJ, Aerni SJ, . Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia. Leuk Res 2009;33:368–376.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Belessi C, Moreno C, . Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007;109:259–270.
   PubMed Web of Science ®Google Scholar
• Martinez H, Rodriguez-Larralde A, Izaguirre MH, . Admixture estimates for Caracas, Venezuela, based on autosomal, Y-chromosome, and mtDNA markers. Hum Biol 2007;79:201–213.
   PubMed Web of Science ®Google Scholar
• Ghia P, Stamatopoulos K, Belessi C, . Geographic patters and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005;105:1678–1685.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Johnson A, . Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002;99:2262–2264.
   PubMed Web of Science ®Google Scholar
• Thorselius M, Krober A, Murray F, . Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational statusBlood 2006;107:2889–2894.
   PubMed Web of Science ®Google Scholar